Jürgen Pache - Concepedia

Author

Jürgen Pache

Deutsches Herzzentrum der Charité

Also Known As

J.ürgen Pache, Jurgen Pache, Jürgen Pache, JÜRGEN PACHE, Jürgen Pache

102

Publications

11.3K

Citations

H-Index

Concepts

All Affiliations

Deutsches Herzzentrum der Charité Klinikum rechts der Isar Deutsches Herzzentrum München Ludwig-Maximilians-Universität München Technical University of Munich

About

Jürgen Pache is an author at Deutsches Herzzentrum der Charité specializing in medicine, cardiovascular disease, and coronary heart disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	41	4.7K
2	Public Health	15	15	1.8K
3	Engineering	1	1	35
4	Health Sciences	1	1	44
5	Biomedical Engineering	1	1	35

Jürgen Pache

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis Adnan Kastrati, Julinda Mehilli, Nicolas von Beckerath, JAMA	2005	605
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial Jürgen Pache, Adnan Kastrati, Julinda Mehilli, Journal of the American College of Cardiology Percutaneous Coronary InterventionIntracoronary StentingCardiovascular DiseaseEndovascular TechniqueStrut Thickness Effect	2003	555
Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement Shpend Elezi, Adnan Kastrati, Jürgen Pache, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseaseDiabetesCoronary Stent PlacementLumen-apposing Metal Stent	1998	496
Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients Alban Dibra, Adnan Kastrati, Julinda Mehilli, New England Journal of Medicine	2005	489
Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction Albert Schömig, Adnan Kastrati, Josef Dirschinger, New England Journal of Medicine	2000	477
5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Gjin Ndrepepa, Klaus Tiroch, Massimiliano Fusaro, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiogenic ShockCardiovascular Disease5-Year Prognostic Value	2010	459
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Robert A. Byrne, Franz–Josef Neumann, Julinda Mehilli, The Lancet Endovascular TechniqueCardiovascular DiseasePaclitaxel-eluting BalloonsPaclitaxel-eluting StentsVascular Surgery	2012	441
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention Adnan Kastrati, Franz‐Josef Neumann, Julinda Mehilli, New England Journal of Medicine	2008	349
Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading Julinda Mehilli, Adnan Kastrati, S. Schulz, Circulation	2009	337
Restenosis after coronary placement of various stent types Adnan Kastrati, Julinda Mehilli, Josef Dirschinger, The American Journal of Cardiology Percutaneous Coronary InterventionCoronary PlacementCardiovascular DiseaseAtherosclerosisCoronary Unit	2001	322

Page 1